RxDoctor Payments Data

Derral Hawthorne, PA

Physician Assistant · Gold Beach, ORNPI 1295169001

Payments from drug & device makers

$953in general payments, 2019–2025

Across 50 payments — averaging $19.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$203
  • AstraZeneca$127
  • Exact Sciences$98
  • Lilly USA, LLC$87
  • GSK$72
  • AbbVie$58
  • plus $307 from 7 others

What the payments were for

  • Food & beverage$93798%
  • Education$162%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$953 in reported general payments places this provider in the 80th percentile of 1,756 physician assistant providers in Oregon.

See all physician assistant providers in Oregon

Medicare billing

Part B allowed, 2024
$34,611
Medicare patients
186
Services billed
595

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide48$47,681
Trelegy ElliptaFluticasone/Umeclidin/Vilanter53$46,665
JulucaDolutegravir/Rilpivirine12$42,367
XareltoRivaroxaban25$36,540
EliquisApixaban45$35,826
JardianceEmpagliflozin20$15,858
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog12$10,790
ShingrixVaricella-Zoster Ge/As01b/Pf46$10,246
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog23$8,214
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog11$5,722
Lantus SolostarInsulin Glargine,hum.Rec.Anlog32$3,443
Atorvastatin Calcium215$3,355
Gabapentin89$3,158
Potassium Chloride81$2,812
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$2,644

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Shingrix$72$56,91199 claims
Novo NordiskOzempic$42$47,68148 claims
Johnson & JohnsonXarelto$58$36,54025 claims
AbbVieSynthroid$58$1,04120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,756 physician assistant providers in Oregon.

Other physician assistant in Gold Beach

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →